US Market Report for Ophthalmic Data Management Systems 2017 - MedCore
General Report Contents
- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
- Market Drivers & Limiters for each chapter segment
- Competitive Analysis for each chapter segment
- Section on recent mergers & acquisitions
Ophthalmic data management systems are being increasingly prioritized by optometrists looking to streamline their patient flow and diagnostic capabilities. The cost of an ophthalmic data management system varies widely depending on the characteristics of the practice and the number of devices that need to be integrated with the system. The overall cost is broken up into several components including the software, server software, hardware and professional services including maintenance and implementation fees. Typically a billing scenario will include a base rate for installation, plus an additional charge for each device that is integrated with the system. Across competitors, there is not currently much variance in pricing. The systems from Carl Zeiss Meditec and Topcon are priced similarly. However, with ongoing innovation in this product category there is potential for a spreading in prices as some of these systems become more established.
Optometrists and ophthalmologists work in an environment where multiple pieces of equipment are routinely used for the diagnosis and treatment of a single patient. For example, to test for the presence of glaucoma, a patient may be assessed with optical coherence tomography (OCT), fundus imagery, perimetry, and some form of tonometer for measurements of intraocular pressure (IOP). Ophthalmic data management systems are diagnostic information and patient profile solutions that allow the practitioner to store, access, and review information in an efficient and clinically meaningful way. The systems allow practitioners to display and compare reports from a single diagnostic tool over an extended period of the patient’s history. For example, fundus imagery of a diabetic retinopathy patient can be compared from the beginning of the onset of the pathology throughout the period of treatment. Alternatively, reports from multiple devices can be reviewed at once to facilitate a highly informed diagnosis. All of these functions can be performed from the practitioners office or using a wireless device.
- EXECUTIVE SUMMARY
- U.S. DIAGNOSTIC OPHTHALMIC DEVICE MARKET OVERVIEW
- COMPETITIVE ANALYSIS
- MARKET TRENDS
- MARKET DEVELOPMENTS
- MARKETS INCLUDED
- KEY REPORT UPDATES
- VERSION HISTORY
- RESEARCH METHODOLOGY
- 1.1 RESEARCH SCOPE
- 1.2 IDATA’S 9-STEP METHODOLOGY
- Step 1: Project Initiation & Team Selection
- Step 2: Prepare Data Systems and Perform Secondary Research
- Step 3: Preparation for Interviews & Questionnaire Design
- Step 4: Performing Primary Research
- Step 5: Research Analysis: Establishing Baseline Estimates
- Step 6: Market Forecast and Analysis
- Step 7: Identify Strategic Opportunities
- Step 8: Final Review and Market Release
- Step 9: Customer Feedback and Market Monitoring
- DISEASE OVERVIEW
- 2.1.1 Glaucoma
- 2.1.2 Diabetic Retinopathy
- 2.1.3 Refractive Error
- 2.1.4 Age-Related Macular Degeneration
- 2.1.5 Astigmatism
- 2.1.6 Cataract
- PRODUCT ASSESSMENT
- 3.1 PRODUCT PORTFOLIOS
- 3.1.1 Ophthalmic Data Management Systems
- 3.2 FDA RECALLS
- 3.2.1 Alcon
- 3.2.2 Abbott Medical Optics (AMO)
- 3.2.3 Topcon
- 3.2.4 Nidek
- 3.3 CLINICAL TRIALS
- 3.3.1 Alcon
- 3.3.2 Carl Zeiss Meditec
- 3.3.3 Topcon
- OPHTHALMIC DATA MANAGEMENT SYSTEMS MARKET
- 4.1 INTRODUCTION
- 4.2 MARKET ANALYSIS AND FORECAST
- 4.3 DRIVERS AND LIMITERS
- 4.3.1 Market Drivers
- 4.3.2 Market Limiters
- 4.4 COMPETITIVE MARKET SHARE ANALYSIS
- ABBREVIATIONS
- APPENDIX: COMPANY PRESS RELEASES
- List of Charts
- Chart 1 1: Diagnostic Ophthalmic Device Market by Segment, U.S., 2013 – 2023
- Chart 1 2: Diagnostic Ophthalmic Device Market Overview, U.S., 2013 & 2023
- Chart 4 1: Ophthalmic Data Management Systems Market, U.S., 2013 – 2023
- Chart 4 2: Leading Competitors, Ophthalmic Data Management Systems Market, U.S., 2016
- List of Figures
Figure 1 1: Diagnostic Ophthalmic Device Market Share Ranking by Segment, U.S., 2016 (1 of 2) - Figure 1 2: Diagnostic Ophthalmic Device Market Share Ranking by Segment, U.S., 2016 (2 of 2)
- Figure 1 3: Companies Researched in this Report, U.S., 2016
- Figure 1 4: Factors Impacting the Diagnostic Ophthalmic Device Market by Segment, U.S. (1 of 2)
- Figure 1 5: Factors Impacting the Diagnostic Ophthalmic Device Market by Segment, U.S. (2 of 2)
- Figure 1 6: Recent Events in the Diagnsotic Ophthalmic Device Market, U.S., 2013 – 2016 (1 of 2)
- Figure 1 7: Recent Events in the Diagnsotic Ophthalmic Device Market, U.S., 2013 – 2016 (2 of 2)
- Figure 1 8: Diagnostic Ophthalmic Device Markets Covered, U.S., 2016 (1 of 2)
- Figure 1 9: Diagnostic Ophthalmic Device Markets Covered, U.S., 2016 (2 of 2)
- Figure 1 10: Key Report Updates
- Figure 1 11: Version History
- Figure 3 1: Ophthalmic Data Management Systems by Company
- Figure 3 2: Class 2 Device Recall Alcon
- Figure 3 3: Class 2 Device Recall Alcon
- Figure 3 4: Class 2 Device Recall Alcon
- Figure 3 5: Class 2 Device Recall Alcon
- Figure 3 6: Class 2 Device Recall Alcon
- Figure 3 7: Class 2 Device Recall Alcon
- Figure 3 8: Class 2 Device Recall Alcon
- Figure 3 9: Class 2 Device Recall Alcon
- Figure 3 10: Class 2 Device Recall Abbott Medical Optics
- Figure 3 11: Class 2 Device Recall Abbott Medical Optics
- Figure 3 12: Class 2 Device Recall Abbott Medical Optics
- Figure 3 13: Class 2 Device Recall Abbott Medical Optics
- Figure 3 14: Class 2 Device Recall Abbott Medical Optics
- Figure 3 15: Class 2 Device Recall Abbott Medical Optics
- Figure 3 16: Class 2 Device Recall Abbott Medical Optics
- Figure 3 17: Class 2 Device Recall Abbott Medical Optics
- Figure 3 18: Class 2 Device Recall Abbott Medical Optics
- Figure 3 19: Class 2 Device Recall Abbott Medical Optics
- Figure 3 20: Class 2 Device Recall Topcon
- Figure 3 21: Class 2 Device Recall Nidek
- Figure 3 22: Class 2 Device Recall Nidek
- Figure 3 23: Clinical Investigation of Corneal Incision Size After Intraocular Lens (IOL) Implantation
- Figure 3 24: Clinical Outcomes Following Treatment With SYSTANE® BALANCE
- Figure 3 25: Clinical Evaluation of DAILIES TOTAL 1® Performance in a Japanese Population
- Figure 3 26: CLEAR CARE® PLUS for Presbyopic Contact Lens Wearers
- Figure 3 27: Clinical Assessment of DAILIES TOTAL1® (DT1) Multifocal
- Figure 3 28: Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%
- Figure 3 29: Pseudophakic Astigmatic Reduction With Verion-LenSx Arcuate Incisions
- Figure 3 30: Glaucoma HFA / OCT Specificity Study
- Figure 3 31: OCT Image Quality Performance Evaluation
- Figure 3 32: Evaluation of the Signal to Noise Ratio at Various Retinal Layers
- Figure 3 33: Slit Lamp Model SL-D-301 and DC-4 Digital Camera Attachment
- Figure 4 1: Ophthalmic Data Management Systems Market, U.S., 2013 – 2023
- Figure 4 2: Drivers and Limiters, Ophthalmic Data Management Systems Market, U.S., 2016
- Figure 4 3: Leading Competitors, Ophthalmic Data Management Systems Market, U.S., 2016
- Figure 6 1: Press Release Summary